Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 421

  • The following term was ignored: -
  • See the search details.
1.

Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.

Reisner SL, Deutsch MB, Peitzmeier SM, White Hughto JM, Cavanaugh TP, Pardee DJ, McLean SA, Panther LA, Gelman M, Mimiaga MJ, Potter JE.

PLoS One. 2018 Mar 14;13(3):e0190172. doi: 10.1371/journal.pone.0190172. eCollection 2018.

2.

Knowledge, attitudes, and practices regarding cervical cancer and screening among women visiting primary health care Centres in Bahrain.

Jassim G, Obeid A, Al Nasheet HA.

BMC Public Health. 2018 Jan 11;18(1):128. doi: 10.1186/s12889-018-5023-7.

3.

[Proposal for the modernization of cervical screening procedure in Hungary].

Koiss R, Boncz I, Hernádi Z, Szentirmay Z.

Orv Hetil. 2017 Dec;158(52):2062-2067. doi: 10.1556/650.2017.30896. Hungarian.

PMID:
29285941
4.

[Study on clinical management of HPV(+)/Pap(-) during cervical cancer screening].

Huang AJ, Zhao Y, Zou XL, Yan J, Zhao C, Cui SH, Li YY, Ren LH, Li JR, Li MZ, Wang Y, Wang JL, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2017 Nov 25;52(11):745-750. doi: 10.3760/cma.j.issn.0529-567X.2017.11.006. Chinese.

PMID:
29179269
5.

Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.

Allen-Leigh B, Uribe-Zúñiga P, León-Maldonado L, Brown BJ, Lörincz A, Salmeron J, Lazcano-Ponce E.

BMC Cancer. 2017 Nov 9;17(1):734. doi: 10.1186/s12885-017-3723-5.

6.

Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.

Sy AU, Hernandez BY, Tareg A, Reichhardt M, Buenconsejo-Lum L.

Cancer Epidemiol. 2017 Oct;50(Pt B):283-288. doi: 10.1016/j.canep.2017.07.008.

7.

Cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in four US-Affiliated Pacific Islands between 2007 and 2015.

Senkomago V, Royalty J, Miller JW, Buenconsejo-Lum LE, Benard VB, Saraiya M.

Cancer Epidemiol. 2017 Oct;50(Pt B):260-267. doi: 10.1016/j.canep.2017.04.011.

8.

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

Barré S, Massetti M, Leleu H, De Bels F.

BMJ Open. 2017 Oct 6;7(10):e014626. doi: 10.1136/bmjopen-2016-014626.

9.

Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.

Rebolj M, Njor S, Lynge E, Preisler S, Ejegod D, Rygaard C, Bonde J.

Cytopathology. 2017 Oct;28(5):419-428. doi: 10.1111/cyt.12451.

PMID:
28901682
10.

Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.

Tao X, Austin RM, Zhang H, Zhang L, Xiao J, Zhou X, Wang L, Zhao C.

Cancer Cytopathol. 2017 Dec;125(12):947-953. doi: 10.1002/cncy.21914. Epub 2017 Sep 8.

PMID:
28885778
11.

Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.

Guo F, Hirth JM, Berenson AB.

J Womens Health (Larchmt). 2017 Oct;26(10):1114-1122. doi: 10.1089/jwh.2017.6424. Epub 2017 Aug 25.

PMID:
28841084
12.

CITRUS, cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening: Design, methods and baseline data of 18,471 women.

Morisada T, Teramoto K, Takano H, Sakamoto I, Nishio H, Iwata T, Hashi A, Katoh R, Okamoto A, Sasaki H, Nakatani E, Teramukai S, Aoki D.

Cancer Epidemiol. 2017 Oct;50(Pt A):60-67. doi: 10.1016/j.canep.2017.07.017. Epub 2017 Aug 16.

PMID:
28818742
13.

Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.

Madzima TR, Vahabi M, Lofters A.

Can Fam Physician. 2017 Aug;63(8):597-601. Review.

14.

Cytology versus HPV testing for cervical cancer screening in the general population.

Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M.

Cochrane Database Syst Rev. 2017 Aug 10;8:CD008587. doi: 10.1002/14651858.CD008587.pub2. Review.

PMID:
28796882
15.

Cervical cancer screening in rural Bhutan with the careHPV test on self-collected samples: an ongoing cross-sectional, population-based study (REACH-Bhutan).

Baussano I, Tshering S, Choden T, Lazzarato F, Tenet V, Plummer M, Franceschi S, Clifford GM, Tshomo U.

BMJ Open. 2017 Jul 19;7(7):e016309. doi: 10.1136/bmjopen-2017-016309.

16.

Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.

McDowell M, Pardee DJ, Peitzmeier S, Reisner SL, Agénor M, Alizaga N, Bernstein I, Potter J.

LGBT Health. 2017 Aug;4(4):252-259. doi: 10.1089/lgbt.2016.0187. Epub 2017 Jun 30.

PMID:
28665783
17.

Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study.

Sun P, Song Y, Ruan G, Mao X, Kang Y, Dong B, Lin F.

J Gynecol Oncol. 2017 Sep;28(5):e50. doi: 10.3802/jgo.2017.28.e50. Epub 2017 Apr 25.

18.

Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.

Cuzick J, Myers O, Lee JH, Shi Y, Gage JC, Hunt WC, Robertson M, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

JAMA Oncol. 2017 Oct 1;3(10):1327-1334. doi: 10.1001/jamaoncol.2017.1040.

19.

Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population.

Chatzistamatiou K, Chatzaki Ε, Constantinidis Τ, Nena E, Tsertanidou A, Agorastos T.

J Obstet Gynaecol. 2017 Nov;37(8):1059-1064. doi: 10.1080/01443615.2017.1323197. Epub 2017 Jun 20.

PMID:
28631511
20.

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.

Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ.

BMJ Open. 2017 Jun 15;7(6):e015048. doi: 10.1136/bmjopen-2016-015048.

Supplemental Content

Loading ...
Support Center